S. Holt et al., Acute cholestasis-induced renal failure: Effects of antioxidants and ligands for the thromboxane A(2) receptor, KIDNEY INT, 55(1), 1999, pp. 271-277
Background. Acute biliary obstruction is associated with the development of
renal impairment and oxidative stress. The F-2-isoprostanes, formed during
oxidant injury, are renal vasoconstrictors acting via thromboxane (TX)-lik
e receptors. We determined whether the formation of F-2-isoprostanes is inc
reased in experimental cholestasis and whether thiol containing antioxidant
s or ligands for the TXA(2) receptor could improve renal function.
Methods. The effects on renal function of acute bile duct ligation (BDL) in
the rat were studied for two days. The consequences of administration of N
-acetylcysteine (NAC), alpha-lipoic acid (LA), the TX receptor antagonist (
TXRA) BAYu3405, or placebo were then examined.
Results. BDL caused a reduction in creatinine clearance from 1.10 +/- 0.05
to 0.55 +/- 0.05 ml/min and sodium excretion from 52 +/- 3 to 17 +/- 3 mu m
ol/hr. Urinary F-2-isoprostanes increased from 14 +/- 2 to 197 +/- 22 pg/ml
following BDL. Renal functional changes were ameliorated by NAC (creatinin
e clearance 0.73 +/- 0.05 ml/min), LA (0.64 +/- 0.03 ml/min), and a TXRA (0
.90 +/- 0.15 ml/min); P < 0.05. Similarly, sodium excretion was increased f
rom 17 +/- 3 mu mol/hr (placebo) to 34 +/- 3 mu mol/hr (NAC), 29 +/- 3 mu m
ol/hr (LA), and 38 +/- 5 mu mol/hr (TXRA); P < 0.005. Hepatic glutathione c
oncentrations increased from 6.5 +/- 0.3 mu mol/g (normal liver) to 8.8 +/-
0.5 mu mol/g (NAC) and 7.7 +/- 0.3 mu mol/g (LA), P < 0.01. However, only
LA markedly inhibited F-2-isoprostane formation (197 +/- 22 to 36 +/- 11 pg
/ml creatinine clearance; P < 0.05). Urinary TXB2 excretion was elevated af
ter BDL (2.2 +/- 0.5 to 111.1 +/- 20.3 pg/min) but was unaffected by NAC an
d LA.
Conclusion. NAG, LA, and TXRA can partially prevent renal dysfunction in ex
perimental cholestasis. The effects of the antioxidants are independent of
their ability to inhibit lipid peroxidation or TX synthesis.